Drug intelligence / Profile preview

N-1H-imidazol-2-yl-N'-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine

Development stage: Unknown
Modality: Small Molecules

Overview

N‑1H‑imidazol‑2‑yl‑N'‑[4‑(1H‑imidazol‑2‑ylamino)phenyl]benzene‑1,4-diamine is a synthetic small molecule with the molecular formula C18H17N7 and a molecular weight of 331.37 g/mol. It is listed in chemical and drug databases as an experimental compound but does not have an assigned pharmacological class or approved therapeutic use. Its mechanism of action, biological targets, clinical indications, and developer information are not available in public sources as of June 2025. The compound is referenced by several research identifiers (CHEMBL74371, DB08331), indicating it has been cataloged for potential screening or research purposes but lacks further characterization regarding its pharmacology or clinical development status[1][2].

Other names: N1-(1H-imidazol-2-yl)-N4-(4-((1H-imidazol-2-yl)amino)phenyl)benzene-1,4-diamine

Beyond the preview

Go deeper on N-1H-imidazol-2-yl-N'-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-1H-imidazol-2-yl-N'-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine.

Explore the full profile